Investing

Windstream, Intercept Pharma Dip into Wednesday's 52-Week Low Club

September 27, 2017: Here are four stocks trading with heavy volume among 52 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by about 4 to 3 and on the Nasdaq advancers led decliners by nearly 3 to 1.

Uniti Group Inc. (NASDAQ: UNIT) dropped about 5.6% Wednesday to post a new 52-week low of $14.77 after closing at $15.65 on Tuesday. The 52-week high is $32.06. Volume was around 8.6 million, more than 3 times the daily average. The company, a former unit of Windstream,may be getting beaten up because investors are wary of its former parent.

Genocea Biosciences Inc. (NASDAQ: GNCA) posted a new 52-week low of $1.20 on Wednesday, down about 4% from Tuesday’s closing price of $1.25. The stock’s 52-week high is $7.29. Volume totaled around 6 million shares, nearly 10 times the daily average. The company said on Tuesday that it was cutting staff and shifting its development focus.

Windstream Holdings Inc. (NASDAQ: WIN) traded flat Wednesday to tie a new 52-week low of $1.75 set at the closing bell on Tuesday. The 52-week high is $10.46. Volume of around 4.4 million shares traded was about 10% higher than the daily average. The company had no specific news.

Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped about 6.6% Wednesday to post a new 52-week low of $54.98 after closing at $58.84 on Tuesday. The stock’s 52-week high is $172.75. Volume of around 3.5 million was more than double the daily average. The company had no specific news Wednesday.

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.